Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study in healthy volunteers to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD0780; the trial has completed to characterize t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• AZD0780

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED